Skip to main content
    L

    LENSAR Inc (LNSR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $5.29
    +0.29 (+5.80%)

    Market Cap: $61.47M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(14/25)
    Avg Surprise
    -32.24%
    Streak
    2 Q

    Upcoming Estimates

    Reports Feb 25, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.09
    Range-$0.10 - -$0.07
    5 analysts
    Revenue Consensus
    $17.20M
    Range$15.68M - $18.48M
    5 analysts
    Reports May 6, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.17
    Range-$0.17 - -$0.17
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current-$0.17
    Revenue Consensus
    $15.80M
    Range$14.80M - $17.60M
    3 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDA1.98x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin56.10%Operating Margin-3.29%
    ROE52.90%ROIC142.16%
    Financial Health
    Debt/Equity0.17xInterest CoverageN/A
    Current Ratio2.25xQuick Ratio0.98x
    Trading Statistics
    Beta1.03Avg Volume71.01K
    52-Week High$12.9452-Week Low$4.30

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 16.9% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 41.9, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$5.20
    SMA 20$5.54
    SMA 50$6.37
    SMA 200$7.06
    EMA 10$5.19
    EMA 20$5.49
    EMA 50$6.08
    EMA 200$7.38

    MACD

    Line: -0.40Signal: -0.38Hist: -0.02

    ADX

    ADX: 41.0+DI: 20.6-DI: 30.4

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down88.0
    PSAR$4.30

    Bollinger Bands

    Upper Band$6.50
    Lower Band$4.59
    %B Position3437%(Upper)
    Band Width0.37

    RSI (14-Day)

    Neutral
    41.9

    Momentum Oscillators

    Stoch %K39.6
    Stoch %D26.0
    Williams %R-43.4
    ROC (10d)-6.7%
    Momentum-0.38
    CCI (20d)-56.1
    MFI (14d)36.7

    Volatility Measures

    ATR (14d)$0.35(6.6%)
    StdDev (20d)0.48
    Hist Vol76.0%(High)

    Volume Flow

    VWAP$5.25
    OBV-1.6M
    AD Line-4.3M
    CMF (20d)-0.101

    Volume Metrics

    Avg Vol (20d)71.5K
    Vol Ratio1.1x
    VWMA (20d)$5.31

    Pivot Points

    R3$5.56
    R2$5.32
    R1$5.16
    Pivot Point$4.92
    S1$4.76
    S2$4.52
    S3$4.36

    Advanced Oscillators

    TSI-36.74
    Ultimate Osc41.0
    KST-175.96

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about LNSR

    LNSR Valuation

    EV/EBITDA
    2.0x
    P/B
    5.9x
    LNSR valuation multiples

    LNSR Profitability: Margins, ROIC and FCF

    LENSAR (LNSR) has a gross margin of 52.0%, an operating margin of -3.3% and a net margin of 56.1%. It posts 142.2% ROIC and a -8.0% FCF margin.

    Gross margin
    52.0%
    Operating margin
    -3.3%
    Net margin
    56.1%
    ROIC
    142.2%
    ROE
    52.9%
    FCF margin
    -8.0%
    LNSR financial statements

    The companies most similar to LENSAR (LNSR) include Sensus Healthcare, Electrocore LLC and Hyperfine.

    Sector: Healthcare

    Companies most similar to LENSAR

    LNSR Analyst Ratings

    LENSAR (LNSR) has a Buy consensus from 3 analysts: 3 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    0
    Buy
    3
    Hold
    0
    Sell
    0
    Strong Sell
    0
    LNSR stock forecast

    LNSR Bull Case vs Bear Case

    Bull case

    • LNSR earns a 142.2% return on invested capital.
    • LNSR has a 56.1% net profit margin.

    Bear case

    • LNSR's quarterly revenue changed -1.3% year over year.

    LNSR Earnings: Beat Rate and Next Report

    LENSAR (LNSR) beat the EPS estimate in 4 of the last 8 quarters (50.0%). Its next report is expected on Feb 25, 2027.

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -12.4%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.09
    LNSR earnings history

    LNSR Earnings Date

    LNSR reports Feb 25, 2027. The date is estimated.

    LNSR Earnings Call

    The latest LNSR earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    See insider activity

    Updated Nov 10, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About LNSR

    When does LNSR report earnings?

    LENSAR Inc (LNSR) is expected to report earnings on Feb 25, 2027.

    Does LNSR pay dividends?

    LENSAR Inc (LNSR) does not currently pay a regular dividend.

    What is LNSR's market cap?

    LENSAR Inc (LNSR) has a market capitalization of $61.47M with a current stock price of $5.29.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.